PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility

Research output: Contribution to journalArticle

1 Scopus citations


Although pharmacogenomics (PGx) offers the promise of ensuring the right patient receives the right medication at the right dose the first time, gene–drug interaction data have yet to be seamlessly integrated into patients’ health records. PGx testing that is preemptive, adaptable, current, and executable (PACE) overcomes the human and technological barriers to successful implementation, thus capitalizing on the affordable cost of such testing and clinical practice guidelines at the point of prescription ordering.

Original languageEnglish (US)
JournalClinical Pharmacology and Therapeutics
StateAccepted/In press - Jan 1 2018
Externally publishedYes


Cite this